NEW YORK (Reuters Health) – A 2.5-mg dose of terbutaline at bedtime appears to prevent hypoglycemia during the night in patients with aggressively treated type 1 diabetes, without…
NEW YORK (Reuters Health) – Long-term treatment with fenofibrate does not seem to reduce atherosclerosis, inflammation or endothelial dysfunction in patients with type 2 diabetes, according to a…
NEW YORK (Reuters Health) – In a prospective study of adult patients at Massachusetts General Hospital in Boston, nearly one in five had elevated glycosylated hemoglobin A (HbA1c)…
NEW YORK (Reuters Health) – Women younger than 65 with diabetes tend to have worse cardiovascular risk profiles than diabetic men of the same age, leading to higher…
NEW YORK (Reuters Health) – New research shows that among the cognitive abilities that are affected by type 2 diabetes, processing speed appears to be the most severely…
NEW YORK (Reuters Health) – In a randomized, controlled long-term study of children with idiopathic short stature who were not growth hormone (GH) deficient, GH treatment, started as…
NEW YORK (Reuters Health) – In patients with unstable type 1 diabetes, hypoglycemia awareness — which often deteriorates over time — can be enhanced with islet transplantation, new…
Dr. Armand Daccache, Associate Director of the Residency Program and Assistant Professor of the Retina / Vitreous Section at the Yale Eye Center, discusses the use of focal…
NEW YORK (Reuters Health) – Routine periodic fasting is associated with reduced incidence of coronary artery disease (CAD) and diabetes, according to findings from the Intermountain Heart Collaborative…
NEW YORK (Reuters Health) – Hypogonadotrophic hypogonadism is present in about a third of men between the ages of 18 to 35 who have type 2 diabetes, researchers…